Published in Women's Health Weekly, March 21st, 2002
This follow-up study showed that women receiving venlafaxine over eight weeks maintained approximately a 60% reduction in their hot flashes. A total of 102 postmenopausal women participated in this investigation. The findings of the eight-week evaluation mirrored the results of the first phase of this study - a four-week double-blinded, randomized study that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly